Variable name | Full model | Reduced model | ||||
---|---|---|---|---|---|---|
Cured OR | 95% CI | P-value | Adjusted OR | 95% CI | P-value | |
Age(years) | ||||||
65 < | 0.633 | 0.107–3.733 | 0.614 | |||
65 > | Ref | |||||
Disease stage | ||||||
I-II | 0.300 | 0.054–1.669 | 0.169 | 3.279 | 0.493–21.793 | 0.219 |
III-IV | Ref | |||||
Menopausal status | ||||||
Premenopausal | 0.561 | 0.139–2.260 | 0.416 | |||
Post menopausal | Ref | |||||
Her2-status | ||||||
Her2-positive | 0.462 | 0.110–1.936 | 0.291 | |||
Her2-negative | Ref | |||||
Purpose of the treatment | ||||||
Neoadjuvant | 0.250 | 0.024–2.636 | 0.249 | |||
Adjuvant | 0.333 | 0.031–3.579 | 0.364 | |||
Recurrence/Advance | Ref | |||||
Smoker | ||||||
Yes | 0.381 | 0.076–1.901 | 0.239 | |||
No | Ref | |||||
History of alcohol consumption | ||||||
Yes | 0.193 | 0.021–1.766 | 0.145 | 0.141 | 0.013–1.521 | 0.106 |
No | Ref | |||||
Use of diuretics | ||||||
Yes | 0.800 | 0.131–4.874 | 0.809 | |||
No | Ref | |||||
Body mass | 1.126 | 0.996–1.273 | 0.058 | |||
Body fat mass | 1.217 | 1.006–1.472 | 0.044 | 0.802 | 0.651–0.988 | 0.038 |
Muscle mass | 1.147 | 0.935–1.406 | 0.188 | |||
BMI | 1.388 | 0.997–1.932 | 0.052 | |||
TP | 1.398 | 0.368–5.310 | 0.623 | |||
Alb | 1.129 | 0.217–5.867 | 0.885 | |||
Hb | 1.452 | 0.935–2.256 | 0.097 | |||
Zn | 1.019 | 0.957–1.086 | 0.559 | |||
BUN | 1.345 | 1.001–1.808 | 0.049 | |||
Energy intake | 1 | 0.998–1.002 | 0.930 | |||
Protein intake | 1.020 | 0.974–1.068 | 0.407 | |||
Carbohydrate intake | 0.997 | 0.985–1.008 | 0.566 | |||
Fat intake | 0.995 | 0.950–1.042 | 0.832 | |||
Zn intake | 1.070 | 0.724–1.581 | 0.733 | |||
Salt equivalent intake | 1.019 | 0.784–1.325 | 0.888 | |||
QOL-ACD vitality | 1.001 | 0.870–1.153 | 0.986 | |||
QOL-ACD physical aspect | 1.060 | 0.866–1.297 | 0.572 | |||
QOL-ACD mental aspect | 1.019 | 0.860–1.208 | 0.826 | |||
QOL-ACD social aspect | 1.032 | 0.873–1.221 | 0.710 |